Vishal Gulati

Venture Partner at Draper Esprit (Private Equity)

Vishal Gulati

Vishal Gulati

Venture Partner at Draper Esprit (Private Equity)

Overview
RelSci Relationships

655

Number of Boards

13

Birthday

1970

Age

48

Relationships
RelSci Relationships are individuals Vishal Gulati likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Co-Founder at Draper Esprit Plc

Relationship likelihood: Strong

Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Venture Partner at Draper Esprit Plc

Relationship likelihood: Strong

Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Venture Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Venture Partner at Draper Esprit Plc

Relationship likelihood: Strong

Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Venture Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Chief Financial Officer, Secretary & Executive Director at Horizon Discovery Group PLC

Relationship likelihood: Strong

Paths to Vishal Gulati
Potential Connections via
Relationship Science
You
Vishal Gulati
Venture Partner at Draper Esprit (Private Equity)
Career History
Venture Partner
Current

Draper Esprit Plc engages in the creation, funding, and development of technology businesses. The firm's portfolio comprises of Trustpilot, Ledger, Perkbox, Revolut, and Graphcore. Its activities include primary direct investments, angel co-investments, and secondary investments. The company was founded by Simon Christopher Cook and Stuart Malcolm Chapman in 2006 and is headquartered in London, the United Kingdom.

Venture Partner
Current

DFJ Esprit is an active manager which aims to fund entrepreneurs with the vision to build leading global companies. The firm seeks to invest in companies which operate in high growth areas and focus on large market opportunities in the technology, media, telecoms and healthcare sectors.DFJ Esprit aims to support entrepreneurs at any stage in the lifecycle of their business, investing 0.5-25 million dollars over the life of an investment. The firm partners with founders and management teams, aiming to create value in the investee companies by backing spinouts from large corporates and universities, investing primary capital to support entrepreneurs in establishing their businesses or providing liquidity to founder teams and angel investors to support strategic shifts or latter phases of growth.

Professional
Prior

The Wellcome Trust Ltd. provides welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded in 1936 and is headquartered in London, UK.

Boards & Committees
Independent Non-Executive Director
2018 - Current

Sensyne Health Plc is a healthcare technology company, which engages in the discovery and development of new medicines. It also develop clinically validated software applications by artificial intelligence comprises prescribed digital therapeutics and hospital systems. Its products include SEND, GDm-Health, and EDGE. The company was founded on June 20, 2018 and is headquartered in Oxford, the United Kingdom.

Director
2016 - Current

Lifesum AB operates a platform that helps make better food choices and improve exercise and reach health goals. Its application combines technology and applied psychology with personal preferences. The company was founded by Tove Westlund, Martin Wahlby, Henrik Torstensson and Marcus Gners in 2008 and is headquartered in Stockholm, Sweden.

Non-Executive Director
2014 - Current

Horizon Discovery Group Plc is a gene editing company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in 2005 and is headquartered in Cambridge, the United Kingdom.

Investments
Details Hidden

Kheiron Medical Technologies Ltd. develops learning powered tools to help radiologists, radiology departments, imaging centers and hospitals. The company was founded by Peter Daniel Kecskemethy and Tobias Rijken and is headquartered in London, the United Kingdom.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vishal Gulati. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vishal Gulati's profile does not indicate a business or promotional relationship of any kind between RelSci and Vishal Gulati.